Medicinal Products

281. Deputy William Aird asked the Minister for Health if she will outline the Government’s position on ensuring equitable access to orphan medicines given the current restrictions and the consequences for those affected; if she will provide timelines for the publication and funding of the new national rare disease plan; and if she will make a statement on the matter. [4531/26]

1047. Deputy Darren O'Rourke asked the Minister for Health an update on the approval status of the drug givinostat; if officials from her Department have been in contact with their counterparts in the North to examine the possibility of children with Duchenne muscular dystrophy accessing treatment in the North as an interim measure; and if she will make a statement on the matter. [4348/26]

1057. Deputy Brian Brennan asked the Minister for Health whether she is considering making Ryeqo available in Ireland for women suffering with endometriosis; and if she will make a statement on the matter. [4403/26]

2205. Deputy Pearse Doherty asked the Minister for Health if she will ensure that adults have access through the health service to burosumab for treatment for hypophosphataemia; and if she will make a statement on the matter. [74617/25]

2220. Deputy Pádraig Rice asked the Minister for Health if her attention has been drawn to an equivalent hormone replacement therapy scheme in another jurisdiction (details supplied); if she will conduct an equality impact assessment; and if she will make a statement on the matter. [74723/25]

2303. Deputy Liam Quaide asked the Minister for Health the current status of supply of estradot (estradiol transdermal) patches in the State; the duration and cause of any supply disruptions affecting this product in 2024 and 2025; the steps taken by her Department and the HSE to mitigate these shortages; and whether she will provide a timeline for full restoration of supply; and if she will make …

2304. Deputy Liam Quaide asked the Minister for Health if she will review the current dispensing arrangements under the free HRT scheme which limit hormone replacement therapy to one month’s supply at a time; the rationale for this restriction; the impact it has had on continuity of care during ongoing supply disruptions, including for estradot patches; if consideration has been given to allowing …

431. Deputy Pádraig Rice asked the Minister for Health to address the issue of access to oral immunotherapy for children with nut allergies; for an update in respect of the HSE senior leadership team’s decision on the medicine in question; and if she will make a statement on the matter. [73118/25]

316. Deputy Niamh Smyth asked the Minister for Health to review the case of a person (details supplied); the reasons this person was refused the treatment referenced in the correspondence; the options available to them; and if she will make a statement on the matter. [70569/25]

323. Deputy Ruairí Ó Murchú asked the Minister for Health if consideration will be given to the inclusion of all ostomy products on the long term illness scheme; if she will remove the need for a prescription for these products; and if she will make a statement on the matter. [70636/25]

364. Deputy Réada Cronin asked the Minister for Health the position regarding the addition of the drug veozah to the free HRT scheme; and if she will make a statement on the matter. [70837/25]

847. Deputy Mairéad Farrell asked the Minister for Health the work her Department is doing to progress the approval from HSE Medicines Management Programme for dupilumab for the treatment of paediatric eosinophilic oesophagitis; and if she will make a statement on the matter. [69050/25]

998. Deputy Albert Dolan asked the Minister for Health if she will introduce a national scheme for improved access to emergency anaphylaxis medication, including adrenaline auto-injectors, along with structured training and guidance for schools, childcare providers and public settings; and if she will make a statement on the matter. [69648/25]

1000. Deputy Albert Dolan asked the Minister for Health if she will work with the Minister for Education and Youth to ensure that all schools have access to stock adrenaline auto-injectors, rather than relying on individual students and their families to supply them; the measures being taken to provide mandatory, standardised training for teachers and school staff so they feel confident and safe i…

1002. Deputy Colm Burke asked the Minister for Health to provide an update on the ongoing independent review by the Health Products Regulatory Authority on the method of sale and supply of codeine containing medicinal products that are currently available without prescription; and if she will make a statement on the matter. [69678/25]

1004. Deputy Colm Burke asked the Minister for Health in the event of the Health Products Regulatory Authority makes recommendations which provide that codeine containing medicinal products can only be made available through prescription, the mechanisms that will be put in place to assist those who are reliant on these products and who have been able to purchase them without prescription; and if s…

1005. Deputy Colm Burke asked the Minister for Health if the review being carried out by the Health Products Regulatory Authority on the method of sale and supply of codeine containing medicinal products are prepared to consider putting in place additional safeguards through pharmacies without the requirement for prescription; and if she will make a statement on the matter. [69681/25]

1047. Deputy Eoghan Kenny asked the Minister for Health if the refusal of an injection for a person (detailed supplied) will be reviewed by the health service; if the reason for the refusal will be outlined; and if she will make a statement on the matter. [70002/25]

1057. Deputy Ruth Coppinger asked the Minister for Health in light of the recent updated statement by the World Health Organisation on the necessity and cost of medication that treats obesity, if she will consider the inclusion of weight loss injections in the drug payment scheme for all those who suffer from obesity. [70174/25]

1059. Deputy Duncan Smith asked the Minister for Health when a decision will be made under the full health technology commissioned by the HSE in respect of the medicine daridoxerant (quviviq); if this will be expedited; and if she will make a statement on the matter. [70202/25]

1078. Deputy Ivana Bacik asked the Minister for Health her views on the granting of access to dupilumab for the treatment of eosinophilic oesophagitis in children up to 12; her engagement with the HSE and advocacy groups in respect of same; and if she will make a statement on the matter. [70235/25]

1083. Deputy Emer Currie asked the Minister for Health if a medication is being considered for the drug payment scheme (details supplied); and if she will make a statement on the matter. [70327/25]

542. Deputy Barry Ward asked the Minister for Health her views on the merits of establishing a priority for the acquisition of EU made pharmaceuticals; and if she will make a statement on the matter. [68985/25]

543. Deputy Barry Ward asked the Minister for Health to detail any research carried out by her Department into ending the acquisition of Israeli made pharmaceuticals; and if she will make a statement on the matter. [68986/25]

237. Deputy Paul Murphy asked the Minister for Health if her attention has been drawn to a charge being placed on blister packs; and if she will instruct her Department to investigate the matter and reverse the decision. [68189/25]